Patients with NAFLD had higher age, BMI, AST, ALT, GGT, TG, FBG, HOMA-IR, subcutaneous fat, visceral fat and lower HDL-C,IL-27 compared to those without NAFLD(Table 2). This evidence concerns the gene IL27 and metabolic dysfunction-associated steatotic liver disease.